Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/48092
Campo DC Valoridioma
dc.contributor.authorChirino, Ricardoen_US
dc.contributor.authorLópez-Guerra, Antonioen_US
dc.contributor.authorFernández, Leandroen_US
dc.contributor.authorBoada, Luis D.en_US
dc.contributor.authorValerón, Pilar F.en_US
dc.contributor.authorDíaz-Chico, Juan C.en_US
dc.contributor.authorDíaz-Chico, Bonifacio N.en_US
dc.contributor.otherDiaz-Chico, Juan-
dc.contributor.otherDominguez-Boada, Luis-
dc.contributor.otherFernandez-Perez, Leandro-
dc.date.accessioned2018-11-23T18:53:15Z-
dc.date.available2018-11-23T18:53:15Z-
dc.date.issued1994en_US
dc.identifier.issn0013-7227en_US
dc.identifier.urihttp://hdl.handle.net/10553/48092-
dc.description.abstractGH participates in the regulation of the expression of several hepatic proteins, some of which are subject to multihormonal control. We have previously shown the participation of glucocorticoids and thyroid hormones in the regulation of the hepatic low affinity glucocorticoid-binding sites (LAGS). Here, we provide evidence that also implicates GH in the endocrine control of the LAGS through the use of several animal models, all of them having a very low or undetectable plasma GH level: the hypothyroid (TX), the hypophysectomized, and the GH-defficient Lewis-derived dwarf rat. In dwarf rats, the level of LAGS was only 35% of that found in normal Lewis rats. Treatment of these rats with human (h) GH significantly increased the LAGS level in a dose-response manner. In TX rats, hGH treatment provoked a significant increase in the LAGS level (from 0.9 +/- 0.2 to 7.2 +/- 0.8 pmol/mg protein), so that it represented about 65% of the level found in intact animals. In both hypothyroid-adrenalectomized and hypophysectomized rats, the isolated effect of hGH was not as pronounced as in TX or dwarf rats; however, a potentiation of the effect of hGH was observed when this hormone was injected together with corticosterone acetate. On the other hand, when hGH, T-3, and corticosterone acetate were given in combination to hypophysectomized rats, hGH and T-3 behaved as agonists of the LAGS induction at T-3 doses lower than or equal to 0.1 mu g/100 g BW and as antagonists at T-3 doses higher than this. When T-4 was used instead of T-3, this hormone was capable of potentiating the effect of hGH at doses lower than or equal to 1.5 mu g/100 g BW. From these results we conclude that 1) GK as well as thyroid and glucocorticoid hormones participate in the endocrine regulation of the LAGS; and 2) under physiological conditions, it is conceivable that GH, thyroid hormones, and glucocorticoids act synergistically in the endocrine regulation of the LAGS.en_US
dc.languageengen_US
dc.relation.ispartofEndocrinology (Philadelphia)en_US
dc.sourceEndocrinology[ISSN 0013-7227],v. 134, p. 1409-1415en_US
dc.subject32 Ciencias médicasen_US
dc.subject3201 Ciencias clínicasen_US
dc.subject.otherMessenger Ribonucleic-Aciden_US
dc.subject.otherDexamethasone-Bindingen_US
dc.subject.otherThyroid-Hormoneen_US
dc.subject.otherEstrogen Sulfotransferaseen_US
dc.subject.otherGene-Expressionen_US
dc.subject.otherFactor-Ien_US
dc.subject.otherReceptoren_US
dc.subject.otherInductionen_US
dc.subject.otherRnaen_US
dc.subject.otherFractionsen_US
dc.titleThe role of growth hormone in regulation of low affinity glucocorticoid-binding sites from male rat liver microsomesen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1210/endo.134.3.8119181en_US
dc.identifier.scopus0028351025-
dc.identifier.isiA1994MZ44300057-
dcterms.isPartOfEndocrinology-
dcterms.sourceEndocrinology[ISSN 0013-7227],v. 134 (3), p. 1409-1415-
dc.contributor.authorscopusid6701324062-
dc.contributor.authorscopusid6506292505-
dc.contributor.authorscopusid7202848203-
dc.contributor.authorscopusid6603916807-
dc.contributor.authorscopusid6603469417-
dc.contributor.authorscopusid6701492347-
dc.contributor.authorscopusid7003603506-
dc.description.lastpage1415en_US
dc.identifier.issue3-
dc.description.firstpage1409en_US
dc.relation.volume134en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.identifier.wosWOS:A1994MZ44300057-
dc.contributor.daisngid880609-
dc.contributor.daisngid12140915-
dc.contributor.daisngid795544-
dc.contributor.daisngid697526-
dc.contributor.daisngid1146740-
dc.contributor.daisngid749099-
dc.contributor.daisngid1724161-
dc.identifier.investigatorRIDH-1527-2015-
dc.identifier.investigatorRIDL-5577-2015-
dc.identifier.investigatorRIDH-1493-2015-
dc.description.numberofpages7en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:CHIRINO, R-
dc.contributor.wosstandardWOS:LOPEZGUERRA, A-
dc.contributor.wosstandardWOS:FERNANDEZ, L-
dc.contributor.wosstandardWOS:BOADA, LD-
dc.contributor.wosstandardWOS:VALERON, PF-
dc.contributor.wosstandardWOS:DIAZCHICO, JC-
dc.contributor.wosstandardWOS:DIAZCHICO, BN-
dc.date.coverdateEnero 1994en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.scieSCIE-
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Diabetes y endocrinología aplicada-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Clínicas-
crisitem.author.deptGIR IUIBS: Medio Ambiente y Salud-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Clínicas-
crisitem.author.deptGIR IUIBS: Medio Ambiente y Salud-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.deptGIR IUIBS: Bioquímica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.deptGIR IUIBS: Bioquímica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.orcid0000-0002-5681-8931-
crisitem.author.orcid0000-0001-7802-465X-
crisitem.author.orcid0000-0002-0195-4565-
crisitem.author.orcid0000-0001-5865-7003-
crisitem.author.orcid0000-0002-0944-990X-
crisitem.author.orcid0000-0002-0944-990X-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameChirino Godoy, Ricardo-
crisitem.author.fullNameLópez Guerra, Antonio Jesús-
crisitem.author.fullNameFernández Pérez, Leandro Francisco-
crisitem.author.fullNameDomínguez Boada, Luis María-
crisitem.author.fullNameFernández Valerón, Josefa Pilar-
crisitem.author.fullNameDíaz Chico, Juan Carlos-
crisitem.author.fullNameDíaz Chico, Juan Carlos-
Colección:Artículos
Vista resumida

Citas SCOPUSTM   

11
actualizado el 17-nov-2024

Citas de WEB OF SCIENCETM
Citations

12
actualizado el 25-feb-2024

Visitas

69
actualizado el 18-mar-2023

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.